Neeraj Koduri

Neeraj Koduri is a first-year student in the MS/MBA Biotechnology dual-degree program at Harvard Business School and the Harvard Graduate School of Arts and Sciences. Before HBS, he was a Senior Director on the Corporate Business Development Transactions team at Eli Lilly, leading M&A and partnership deals with emerging biotechnology companies. Prior to Lilly, Neeraj served as the Business Development and Strategy Lead at DICE Therapeutics, an immunology focused biotech, supporting the company through its IPO and eventual sale to Lilly. He began his career in life sciences investment banking at Wells Fargo Securities and biotechnology equity research at Evercore ISI. Neeraj earned his undergraduate degree from the University of Southern California.